Share Price and Basic Stock Data
Last Updated: January 10, 2026, 6:53 am
| PEG Ratio | 0.47 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Nucleus Software Exports Ltd operates in the IT Consulting & Software industry, with its current market capitalization standing at ₹2,405 Cr and a share price of ₹914. The company reported a consistent upward trend in sales, with total revenue rising from ₹497 Cr in FY 2022 to ₹634 Cr in FY 2023, and further projected at ₹832 Cr for FY 2025. The quarterly sales figures reveal fluctuations, peaking at ₹207 Cr in Q1 FY 2024 and slightly declining to ₹204 Cr in Q4 FY 2024. This indicates a robust demand for its software solutions, particularly in the banking and financial services sectors. The trailing twelve-month (TTM) revenue reached ₹866 Cr, showcasing Nucleus Software’s ability to sustain its market presence amidst competitive pressures. The company’s revenue growth reflects its strategic initiatives and client acquisition efforts, positioning it favorably within the sector.
Profitability and Efficiency Metrics
The company’s profitability metrics illustrate its operational efficiency, with a reported net profit of ₹161 Cr and a return on equity (ROE) of 16.8%. The operating profit margin (OPM) stood at 11%, indicating effective cost management despite the competitive landscape. In FY 2023, Nucleus Software recorded an operating profit of ₹157 Cr, translating to an OPM of 25%, which is significantly higher than the sector average. The interest coverage ratio (ICR) is exceptionally strong at 312.81x, reflecting the company’s ability to meet its financial obligations comfortably. However, the operating profit declined to ₹168 Cr in FY 2025, presenting a risk of diminishing margins if trends continue. The cash conversion cycle (CCC) is reported at 60 days, suggesting effective working capital management, although this metric could be improved to enhance liquidity further.
Balance Sheet Strength and Financial Ratios
Nucleus Software’s balance sheet exhibits significant strength, with reserves amounting to ₹822 Cr and minimal borrowings of ₹8 Cr, underscoring its low leverage and financial stability. The company’s book value per share increased to ₹309.24 in FY 2025, reflecting a solid asset base. Financial ratios indicate robust performance, with a return on capital employed (ROCE) of 22.6% and a price-to-book value (P/BV) ratio of 2.59x, which aligns with sector norms. The current ratio stands at 1.93, suggesting adequate liquidity to cover short-term liabilities. However, the total liabilities rose to ₹1,230 Cr, which could pose a risk if not managed prudently. This increase in liabilities needs to be monitored closely to ensure that the company maintains its financial health amid rising operational demands.
Shareholding Pattern and Investor Confidence
The shareholding pattern of Nucleus Software reflects strong promoter confidence, with promoters holding 73.59% of the equity as of September 2025. This level of insider ownership typically indicates a commitment to the company’s long-term strategy. Foreign institutional investors (FIIs) account for 5.18%, while domestic institutional investors (DIIs) hold 1.49%, indicating a moderate level of institutional interest. The number of shareholders has fluctuated, currently at 42,192, suggesting an active retail investor base. Despite a slight decline in public ownership to 19.75%, the overall distribution reflects reasonable investor confidence. However, the relatively low stake by FIIs and DIIs may indicate cautious sentiment towards broader market conditions or sector-specific challenges, warranting close observation for future shifts in ownership dynamics.
Outlook, Risks, and Final Insight
Looking ahead, Nucleus Software faces a mix of opportunities and challenges. The ongoing demand for digital transformation in financial services presents growth potential; however, the company must navigate risks such as margin pressures and increasing competition in the IT consulting space. The decline in operating profit from ₹220 Cr in FY 2024 to ₹168 Cr in FY 2025 raises concerns about sustainability in profitability. Additionally, the rising total liabilities could impact financial flexibility if not managed effectively. The company’s strong balance sheet and high ICR provide a buffer against adverse market conditions, yet it needs to enhance its operational efficiency to maintain competitive margins. Overall, Nucleus Software’s performance in the coming periods will hinge on its ability to innovate and adapt to the rapidly evolving technological landscape while managing its financial health prudently.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| IDream Film Infrastructure Company Ltd | 3.55 Cr. | 236 | 236/103 | 302 | 0.00 % | % | % | 10.0 | |
| I Power Solutions India Ltd | 13.2 Cr. | 22.3 | 22.3/15.1 | 11.0 | 0.00 % | 11.6 % | 16.9 % | 10.0 | |
| Hypersoft Technologies Ltd | 133 Cr. | 81.6 | 101/18.4 | 65.0 | 9.97 | 0.00 % | 20.6 % | 9.07 % | 10.0 |
| Euphoria Infotech (India) Ltd | 10.2 Cr. | 35.2 | 64.9/33.1 | 6.89 | 58.7 | 0.00 % | 16.2 % | 11.5 % | 10.0 |
| AccelerateBS India Ltd | 26.5 Cr. | 77.0 | 165/67.0 | 18.0 | 15.0 | 1.30 % | 22.2 % | 17.6 % | 10.0 |
| Industry Average | 122,410.31 Cr | 847.51 | 46.85 | 158.22 | 0.76% | 20.61% | 18.63% | 7.00 |
Quarterly Result
| Metric | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 130 | 169 | 206 | 207 | 205 | 204 | 210 | 195 | 202 | 206 | 229 | 218 | 214 |
| Expenses | 119 | 121 | 123 | 144 | 153 | 156 | 152 | 166 | 170 | 172 | 154 | 184 | 190 |
| Operating Profit | 11 | 48 | 83 | 63 | 52 | 48 | 58 | 29 | 32 | 33 | 74 | 34 | 23 |
| OPM % | 9% | 28% | 40% | 30% | 25% | 23% | 28% | 15% | 16% | 16% | 33% | 16% | 11% |
| Other Income | 9 | 9 | 10 | 13 | 12 | 12 | 14 | 15 | 19 | 16 | 17 | 18 | 16 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 5 | 5 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 3 | 3 | 4 |
| Profit before tax | 15 | 52 | 89 | 72 | 60 | 56 | 68 | 40 | 47 | 45 | 88 | 48 | 35 |
| Tax % | 26% | 26% | 24% | 25% | 26% | 26% | 24% | 24% | 29% | 22% | 26% | 27% | 26% |
| Net Profit | 11 | 38 | 68 | 54 | 45 | 41 | 52 | 30 | 33 | 35 | 65 | 35 | 26 |
| EPS in Rs | 4.12 | 14.32 | 25.27 | 20.01 | 16.65 | 15.43 | 19.47 | 11.28 | 12.56 | 13.28 | 24.60 | 13.37 | 9.99 |
Last Updated: December 29, 2025, 6:35 pm
Below is a detailed analysis of the quarterly data for Nucleus Software Exports Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Sales, as of Sep 2025, the value is 214.00 Cr.. The value appears to be declining and may need further review. It has decreased from 218.00 Cr. (Jun 2025) to 214.00 Cr., marking a decrease of 4.00 Cr..
- For Expenses, as of Sep 2025, the value is 190.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 184.00 Cr. (Jun 2025) to 190.00 Cr., marking an increase of 6.00 Cr..
- For Operating Profit, as of Sep 2025, the value is 23.00 Cr.. The value appears to be declining and may need further review. It has decreased from 34.00 Cr. (Jun 2025) to 23.00 Cr., marking a decrease of 11.00 Cr..
- For OPM %, as of Sep 2025, the value is 11.00%. The value appears to be declining and may need further review. It has decreased from 16.00% (Jun 2025) to 11.00%, marking a decrease of 5.00%.
- For Other Income, as of Sep 2025, the value is 16.00 Cr.. The value appears to be declining and may need further review. It has decreased from 18.00 Cr. (Jun 2025) to 16.00 Cr., marking a decrease of 2.00 Cr..
- For Interest, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 0.00 Cr..
- For Depreciation, as of Sep 2025, the value is 4.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 3.00 Cr. (Jun 2025) to 4.00 Cr., marking an increase of 1.00 Cr..
- For Profit before tax, as of Sep 2025, the value is 35.00 Cr.. The value appears to be declining and may need further review. It has decreased from 48.00 Cr. (Jun 2025) to 35.00 Cr., marking a decrease of 13.00 Cr..
- For Tax %, as of Sep 2025, the value is 26.00%. The value appears to be improving (decreasing) as expected. It has decreased from 27.00% (Jun 2025) to 26.00%, marking a decrease of 1.00%.
- For Net Profit, as of Sep 2025, the value is 26.00 Cr.. The value appears to be declining and may need further review. It has decreased from 35.00 Cr. (Jun 2025) to 26.00 Cr., marking a decrease of 9.00 Cr..
- For EPS in Rs, as of Sep 2025, the value is 9.99. The value appears to be declining and may need further review. It has decreased from 13.37 (Jun 2025) to 9.99, marking a decrease of 3.38.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 4:53 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 346 | 353 | 349 | 372 | 412 | 484 | 521 | 514 | 497 | 634 | 826 | 832 | 866 |
| Expenses | 278 | 287 | 318 | 319 | 353 | 405 | 427 | 384 | 460 | 478 | 606 | 664 | 701 |
| Operating Profit | 68 | 66 | 31 | 54 | 59 | 79 | 94 | 129 | 37 | 157 | 220 | 168 | 165 |
| OPM % | 20% | 19% | 9% | 14% | 14% | 16% | 18% | 25% | 7% | 25% | 27% | 20% | 19% |
| Other Income | 24 | 33 | 26 | 32 | 29 | 27 | 37 | 39 | 35 | 34 | 51 | 66 | 66 |
| Interest | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Depreciation | 8 | 12 | 12 | 11 | 7 | 10 | 14 | 14 | 15 | 19 | 15 | 15 | 14 |
| Profit before tax | 83 | 87 | 44 | 74 | 80 | 96 | 117 | 154 | 56 | 171 | 256 | 219 | 216 |
| Tax % | 23% | 25% | 26% | 11% | 22% | 23% | 24% | 23% | 26% | 25% | 25% | 26% | |
| Net Profit | 64 | 65 | 32 | 66 | 63 | 75 | 89 | 118 | 41 | 128 | 192 | 163 | 161 |
| EPS in Rs | 19.87 | 19.98 | 10.03 | 20.43 | 21.54 | 25.67 | 30.64 | 40.62 | 15.28 | 47.73 | 71.56 | 61.92 | 61.24 |
| Dividend Payout % | 30% | 25% | 50% | 24% | 37% | 35% | 29% | 22% | 46% | 21% | 17% | 20% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 1.56% | -50.77% | 106.25% | -4.55% | 19.05% | 18.67% | 32.58% | -65.25% | 212.20% | 50.00% | -15.10% |
| Change in YoY Net Profit Growth (%) | 0.00% | -52.33% | 157.02% | -110.80% | 23.59% | -0.38% | 13.92% | -97.84% | 277.45% | -162.20% | -65.10% |
Nucleus Software Exports Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 9% |
| 5 Years: | 10% |
| 3 Years: | 19% |
| TTM: | 5% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 9% |
| 5 Years: | 10% |
| 3 Years: | 72% |
| TTM: | 0% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 16% |
| 5 Years: | 15% |
| 3 Years: | 36% |
| 1 Year: | -24% |
| Return on Equity | |
|---|---|
| 10 Years: | 15% |
| 5 Years: | 17% |
| 3 Years: | 20% |
| Last Year: | 17% |
Last Updated: September 5, 2025, 11:50 am
Balance Sheet
Last Updated: December 10, 2025, 3:10 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 32 | 32 | 32 | 32 | 29 | 29 | 29 | 29 | 27 | 27 | 27 | 26 | 26 |
| Reserves | 365 | 406 | 425 | 503 | 432 | 480 | 532 | 643 | 467 | 584 | 751 | 788 | 822 |
| Borrowings | 0 | 0 | 1 | 0 | 0 | 0 | 6 | 6 | 2 | 6 | 5 | 2 | 8 |
| Other Liabilities | 116 | 118 | 123 | 131 | 184 | 177 | 196 | 206 | 241 | 257 | 332 | 337 | 373 |
| Total Liabilities | 513 | 556 | 581 | 665 | 645 | 685 | 763 | 885 | 737 | 874 | 1,114 | 1,153 | 1,230 |
| Fixed Assets | 61 | 58 | 54 | 48 | 48 | 47 | 57 | 50 | 59 | 50 | 59 | 61 | 77 |
| CWIP | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 1 | 1 | 0 | 0 |
| Investments | 224 | 170 | 245 | 441 | 387 | 424 | 475 | 635 | 480 | 525 | 649 | 641 | 676 |
| Other Assets | 228 | 328 | 281 | 176 | 210 | 214 | 231 | 200 | 198 | 298 | 406 | 451 | 477 |
| Total Assets | 513 | 556 | 581 | 665 | 645 | 685 | 763 | 885 | 737 | 874 | 1,114 | 1,153 | 1,230 |
Below is a detailed analysis of the balance sheet data for Nucleus Software Exports Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 26.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 26.00 Cr..
- For Reserves, as of Sep 2025, the value is 822.00 Cr.. The value appears strong and on an upward trend. It has increased from 788.00 Cr. (Mar 2025) to 822.00 Cr., marking an increase of 34.00 Cr..
- For Borrowings, as of Sep 2025, the value is 8.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 2.00 Cr. (Mar 2025) to 8.00 Cr., marking an increase of 6.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 373.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 337.00 Cr. (Mar 2025) to 373.00 Cr., marking an increase of 36.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 1,230.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1,153.00 Cr. (Mar 2025) to 1,230.00 Cr., marking an increase of 77.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 77.00 Cr.. The value appears strong and on an upward trend. It has increased from 61.00 Cr. (Mar 2025) to 77.00 Cr., marking an increase of 16.00 Cr..
- For CWIP, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Investments, as of Sep 2025, the value is 676.00 Cr.. The value appears strong and on an upward trend. It has increased from 641.00 Cr. (Mar 2025) to 676.00 Cr., marking an increase of 35.00 Cr..
- For Other Assets, as of Sep 2025, the value is 477.00 Cr.. The value appears strong and on an upward trend. It has increased from 451.00 Cr. (Mar 2025) to 477.00 Cr., marking an increase of 26.00 Cr..
- For Total Assets, as of Sep 2025, the value is 1,230.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,153.00 Cr. (Mar 2025) to 1,230.00 Cr., marking an increase of 77.00 Cr..
Notably, the Reserves (822.00 Cr.) exceed the Borrowings (8.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 68.00 | 66.00 | 30.00 | 54.00 | 59.00 | 79.00 | 88.00 | 123.00 | 35.00 | 151.00 | 215.00 | 166.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 44 | 87 | 90 | 60 | 70 | 54 | 63 | 63 | 61 | 100 | 73 | 60 |
| Inventory Days | ||||||||||||
| Days Payable | ||||||||||||
| Cash Conversion Cycle | 44 | 87 | 90 | 60 | 70 | 54 | 63 | 63 | 61 | 100 | 73 | 60 |
| Working Capital Days | -5 | 14 | 7 | -43 | -66 | -51 | -53 | -61 | -77 | -16 | -38 | -43 |
| ROCE % | 21% | 19% | 10% | 15% | 16% | 19% | 21% | 22% | 6% | 27% | 32% | 23% |
Mutual Fund Holdings
| Fund Name | No of Shares | AUM (%) | Amount Invested (Cr) | Previous Number of Shares | Previous Date | Percentage Change |
|---|---|---|---|---|---|---|
| WhiteOak Capital Flexi Cap Fund | 167,297 | 0.23 | 15.5 | 113,333 | 2025-12-08 02:20:10 | 47.62% |
| WhiteOak Capital Mid Cap Fund | 30,394 | 0.06 | 2.82 | 63,549 | 2025-12-15 03:10:46 | -52.17% |
| WhiteOak Capital ELSS Tax Saver Fund | 9,404 | 0.19 | 0.87 | 13,802 | 2025-12-15 03:10:46 | -31.86% |
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 61.40 | 71.56 | 47.73 | 14.28 | 40.62 |
| Diluted EPS (Rs.) | 61.40 | 71.56 | 47.73 | 14.28 | 40.62 |
| Cash EPS (Rs.) | 67.53 | 77.01 | 54.73 | 21.03 | 45.39 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 309.24 | 290.41 | 228.11 | 184.38 | 231.41 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 309.24 | 290.41 | 228.11 | 184.38 | 231.41 |
| Revenue From Operations / Share (Rs.) | 316.08 | 308.72 | 237.00 | 185.73 | 176.84 |
| PBDIT / Share (Rs.) | 89.10 | 101.34 | 71.28 | 26.78 | 58.16 |
| PBIT / Share (Rs.) | 83.48 | 95.91 | 64.29 | 21.03 | 53.38 |
| PBT / Share (Rs.) | 83.19 | 95.55 | 63.91 | 20.73 | 52.96 |
| Net Profit / Share (Rs.) | 61.91 | 71.57 | 47.74 | 15.28 | 40.62 |
| NP After MI And SOA / Share (Rs.) | 61.91 | 71.57 | 47.74 | 15.28 | 40.62 |
| PBDIT Margin (%) | 28.18 | 32.82 | 30.07 | 14.41 | 32.88 |
| PBIT Margin (%) | 26.41 | 31.06 | 27.12 | 11.32 | 30.18 |
| PBT Margin (%) | 26.32 | 30.95 | 26.96 | 11.16 | 29.95 |
| Net Profit Margin (%) | 19.58 | 23.18 | 20.14 | 8.22 | 22.96 |
| NP After MI And SOA Margin (%) | 19.58 | 23.18 | 20.14 | 8.22 | 22.96 |
| Return on Networth / Equity (%) | 20.01 | 24.64 | 20.92 | 8.28 | 17.55 |
| Return on Capital Employeed (%) | 25.25 | 31.36 | 26.84 | 10.84 | 22.57 |
| Return On Assets (%) | 14.13 | 17.19 | 14.61 | 5.55 | 13.33 |
| Asset Turnover Ratio (%) | 0.73 | 0.83 | 0.74 | 0.56 | 0.56 |
| Current Ratio (X) | 1.93 | 2.07 | 2.07 | 2.09 | 3.11 |
| Quick Ratio (X) | 1.93 | 2.07 | 2.07 | 2.09 | 3.11 |
| Dividend Payout Ratio (NP) (%) | 20.53 | 13.97 | 14.66 | 42.58 | 7.38 |
| Dividend Payout Ratio (CP) (%) | 18.82 | 12.98 | 12.79 | 30.94 | 6.60 |
| Earning Retention Ratio (%) | 79.47 | 86.03 | 85.34 | 57.42 | 92.62 |
| Cash Earning Retention Ratio (%) | 81.18 | 87.02 | 87.21 | 69.06 | 93.40 |
| Interest Coverage Ratio (X) | 312.81 | 285.58 | 187.09 | 88.51 | 138.44 |
| Interest Coverage Ratio (Post Tax) (X) | 218.33 | 202.68 | 126.28 | 51.51 | 97.68 |
| Enterprise Value (Cr.) | 1988.60 | 3091.48 | 1658.15 | 1054.42 | 1353.67 |
| EV / Net Operating Revenue (X) | 2.39 | 3.74 | 2.61 | 2.12 | 2.64 |
| EV / EBITDA (X) | 8.48 | 11.40 | 8.69 | 14.71 | 8.01 |
| MarketCap / Net Operating Revenue (X) | 2.54 | 3.83 | 2.69 | 2.23 | 2.72 |
| Retention Ratios (%) | 79.46 | 86.02 | 85.33 | 57.41 | 92.61 |
| Price / BV (X) | 2.59 | 4.07 | 2.80 | 2.25 | 2.08 |
| Price / Net Operating Revenue (X) | 2.54 | 3.83 | 2.69 | 2.23 | 2.72 |
| EarningsYield | 0.07 | 0.06 | 0.07 | 0.03 | 0.08 |
After reviewing the key financial ratios for Nucleus Software Exports Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 61.40. This value is within the healthy range. It has decreased from 71.56 (Mar 24) to 61.40, marking a decrease of 10.16.
- For Diluted EPS (Rs.), as of Mar 25, the value is 61.40. This value is within the healthy range. It has decreased from 71.56 (Mar 24) to 61.40, marking a decrease of 10.16.
- For Cash EPS (Rs.), as of Mar 25, the value is 67.53. This value is within the healthy range. It has decreased from 77.01 (Mar 24) to 67.53, marking a decrease of 9.48.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 309.24. It has increased from 290.41 (Mar 24) to 309.24, marking an increase of 18.83.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 309.24. It has increased from 290.41 (Mar 24) to 309.24, marking an increase of 18.83.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 316.08. It has increased from 308.72 (Mar 24) to 316.08, marking an increase of 7.36.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 89.10. This value is within the healthy range. It has decreased from 101.34 (Mar 24) to 89.10, marking a decrease of 12.24.
- For PBIT / Share (Rs.), as of Mar 25, the value is 83.48. This value is within the healthy range. It has decreased from 95.91 (Mar 24) to 83.48, marking a decrease of 12.43.
- For PBT / Share (Rs.), as of Mar 25, the value is 83.19. This value is within the healthy range. It has decreased from 95.55 (Mar 24) to 83.19, marking a decrease of 12.36.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 61.91. This value is within the healthy range. It has decreased from 71.57 (Mar 24) to 61.91, marking a decrease of 9.66.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 61.91. This value is within the healthy range. It has decreased from 71.57 (Mar 24) to 61.91, marking a decrease of 9.66.
- For PBDIT Margin (%), as of Mar 25, the value is 28.18. This value is within the healthy range. It has decreased from 32.82 (Mar 24) to 28.18, marking a decrease of 4.64.
- For PBIT Margin (%), as of Mar 25, the value is 26.41. This value exceeds the healthy maximum of 20. It has decreased from 31.06 (Mar 24) to 26.41, marking a decrease of 4.65.
- For PBT Margin (%), as of Mar 25, the value is 26.32. This value is within the healthy range. It has decreased from 30.95 (Mar 24) to 26.32, marking a decrease of 4.63.
- For Net Profit Margin (%), as of Mar 25, the value is 19.58. This value exceeds the healthy maximum of 10. It has decreased from 23.18 (Mar 24) to 19.58, marking a decrease of 3.60.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 19.58. This value is within the healthy range. It has decreased from 23.18 (Mar 24) to 19.58, marking a decrease of 3.60.
- For Return on Networth / Equity (%), as of Mar 25, the value is 20.01. This value is within the healthy range. It has decreased from 24.64 (Mar 24) to 20.01, marking a decrease of 4.63.
- For Return on Capital Employeed (%), as of Mar 25, the value is 25.25. This value is within the healthy range. It has decreased from 31.36 (Mar 24) to 25.25, marking a decrease of 6.11.
- For Return On Assets (%), as of Mar 25, the value is 14.13. This value is within the healthy range. It has decreased from 17.19 (Mar 24) to 14.13, marking a decrease of 3.06.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.73. It has decreased from 0.83 (Mar 24) to 0.73, marking a decrease of 0.10.
- For Current Ratio (X), as of Mar 25, the value is 1.93. This value is within the healthy range. It has decreased from 2.07 (Mar 24) to 1.93, marking a decrease of 0.14.
- For Quick Ratio (X), as of Mar 25, the value is 1.93. This value is within the healthy range. It has decreased from 2.07 (Mar 24) to 1.93, marking a decrease of 0.14.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 20.53. This value is within the healthy range. It has increased from 13.97 (Mar 24) to 20.53, marking an increase of 6.56.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 18.82. This value is below the healthy minimum of 20. It has increased from 12.98 (Mar 24) to 18.82, marking an increase of 5.84.
- For Earning Retention Ratio (%), as of Mar 25, the value is 79.47. This value exceeds the healthy maximum of 70. It has decreased from 86.03 (Mar 24) to 79.47, marking a decrease of 6.56.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 81.18. This value exceeds the healthy maximum of 70. It has decreased from 87.02 (Mar 24) to 81.18, marking a decrease of 5.84.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 312.81. This value is within the healthy range. It has increased from 285.58 (Mar 24) to 312.81, marking an increase of 27.23.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 218.33. This value is within the healthy range. It has increased from 202.68 (Mar 24) to 218.33, marking an increase of 15.65.
- For Enterprise Value (Cr.), as of Mar 25, the value is 1,988.60. It has decreased from 3,091.48 (Mar 24) to 1,988.60, marking a decrease of 1,102.88.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 2.39. This value is within the healthy range. It has decreased from 3.74 (Mar 24) to 2.39, marking a decrease of 1.35.
- For EV / EBITDA (X), as of Mar 25, the value is 8.48. This value is within the healthy range. It has decreased from 11.40 (Mar 24) to 8.48, marking a decrease of 2.92.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 2.54. This value is within the healthy range. It has decreased from 3.83 (Mar 24) to 2.54, marking a decrease of 1.29.
- For Retention Ratios (%), as of Mar 25, the value is 79.46. This value exceeds the healthy maximum of 70. It has decreased from 86.02 (Mar 24) to 79.46, marking a decrease of 6.56.
- For Price / BV (X), as of Mar 25, the value is 2.59. This value is within the healthy range. It has decreased from 4.07 (Mar 24) to 2.59, marking a decrease of 1.48.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 2.54. This value is within the healthy range. It has decreased from 3.83 (Mar 24) to 2.54, marking a decrease of 1.29.
- For EarningsYield, as of Mar 25, the value is 0.07. This value is below the healthy minimum of 5. It has increased from 0.06 (Mar 24) to 0.07, marking an increase of 0.01.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Nucleus Software Exports Ltd:
- Net Profit Margin: 19.58%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 25.25% (Industry Average ROCE: 20.61%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 20.01% (Industry Average ROE: 18.63%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 218.33
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 1.93
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 14.9 (Industry average Stock P/E: 46.85)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 19.58%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| IT Consulting & Software | 33-35, Thyagraj Nagar Market, New Delhi Delhi 110003 | Contact not found |
| Management | |
|---|---|
| Name | Position Held |
| Mr. S M Acharya | Chairman(NonExe.&Ind.Director) |
| Mr. Vishnu R Dusad | Managing Director |
| Mr. Anurag Mantri | Executive Director & COO |
| Mr. Parag Bhise | Executive Director & CEO |
| Mr. Shekar Viswanathan | Ind. Non-Executive Director |
| Dr. Ritika Dusad | Executive Director |
| Mr. Prakash Chandra Kandpal | Ind. Non-Executive Director |
| Ms. Yasmin Javeri Krishan | Ind. Non-Executive Director |
FAQ
What is the intrinsic value of Nucleus Software Exports Ltd?
Nucleus Software Exports Ltd's intrinsic value (as of 12 January 2026) is ₹653.66 which is 28.33% lower the current market price of ₹912.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's ₹2,401 Cr. market cap, FY2025-2026 high/low of ₹1,378/724, reserves of ₹822 Cr, and liabilities of ₹1,230 Cr.
What is the Market Cap of Nucleus Software Exports Ltd?
The Market Cap of Nucleus Software Exports Ltd is 2,401 Cr..
What is the current Stock Price of Nucleus Software Exports Ltd as on 12 January 2026?
The current stock price of Nucleus Software Exports Ltd as on 12 January 2026 is ₹912.
What is the High / Low of Nucleus Software Exports Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Nucleus Software Exports Ltd stocks is ₹1,378/724.
What is the Stock P/E of Nucleus Software Exports Ltd?
The Stock P/E of Nucleus Software Exports Ltd is 14.9.
What is the Book Value of Nucleus Software Exports Ltd?
The Book Value of Nucleus Software Exports Ltd is 322.
What is the Dividend Yield of Nucleus Software Exports Ltd?
The Dividend Yield of Nucleus Software Exports Ltd is 1.37 %.
What is the ROCE of Nucleus Software Exports Ltd?
The ROCE of Nucleus Software Exports Ltd is 22.6 %.
What is the ROE of Nucleus Software Exports Ltd?
The ROE of Nucleus Software Exports Ltd is 16.8 %.
What is the Face Value of Nucleus Software Exports Ltd?
The Face Value of Nucleus Software Exports Ltd is 10.0.